OUR RELIABLE RESEARCH & BUSINESS PARTNERS

Kyoto Prefectural University of Medicine and Orthorebirth have been jointly conducting the research on the treatment of osteoporotic vertebral body fractures using ReBOSSIS-J impregnated with PRP (platelet rich plasma). In the future, the technology of this joint research shall be utilized and aimed to develop the application to the treatment of all fractures caused by osteoporosis.

Meiji University and ORTHOREBIRTH have been jointly studying to develop Antibacterial Cottony-Type, Synthetic Bone-Void-Filling Materials. This antibacterial type is to prevent any surgical site (bone or joint) from infected by bacteria or virus at the time of operation. Nagoya Institute of Technology (NIT) and Keio University has also participated in this joint development.

Dr. Kasuga at Nagoya Institute of Technology is the originator of ReBOSSIS. ReBOSSIS is featured with its cottony-shape. Dr. Kasuga made a basic but great research & study to invent this cottony shape. Still now, ORTHOREBIRTH has been working with Dr. Kasuga, trying to create much higher-quality type synthetic bone-void-filling materials, new types of scaffolding materials based on our Microfiber Technology and other innovative medical products. Dr. Kasuga also joins our study to develop Antibacterial Cottony-Type, Synthetic Bone-Void-Filling Materials.

Theradaptive, Inc. is a therapeutics company that develops and commercializes products for targeted therapeutics delivery and has current programs in regenerative tissue repair and immuno oncology. The underlying technology was developed at MIT (Massachusetts Institute of Technology) in the United States. By combining Theradaptive’s technology for engineering material-binding protein biologics with OrthoRebirth’s cotton-shaped bone void fillers, we are collaborating to develop a new composite material for practical use that promotes bone regeneration.

University of the Ryukyus and ORTHOREBIRTH has been jointly making a research and study on the regenerative medicine by use of adipose stem cells. We aim to develop a new medical technology based on this joint study and apply such new technology to regenerative medicine in different ways. For example, to treat a large-sized defective part of bone, reconstruct breast, regenerate solid organs, etc.